Trifocal lenses

EyeCare Partners Announces New Refractive Cataract Anterior Segment Fellowship and Launch of ECP Foundation

Retrieved on: 
Thursday, April 4, 2024
Optical, Surgery, Health, Other Education, Philanthropy, Education, Foundation, Training, Disease burden, Partner, ECP, RCAS, Density, Intraocular lens, Growth, Convention, Refractive surgery, Physician, ASCRS, Telecanthus, Knowledge, Research, Meibomian gland dysfunction, Fellow, Trifocal lenses, Science, Patient satisfaction, Cataract, Mentorship, Quality of life, Surgeon, Society, Ophthalmology, Nursing

EyeCare Partners (ECP), the nation’s leading provider of clinically integrated eye care, continues to advance leadership and research at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting.

Key Points: 
  • EyeCare Partners (ECP), the nation’s leading provider of clinically integrated eye care, continues to advance leadership and research at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting.
  • The company is launching two new initiatives to elevate eye care – the Refractive Cataract Anterior Segment (RCAS) Fellowship and the ECP Foundation.
  • This one-year program provides residency graduates comprehensive training in the latest advancements in refractive cataract and anterior segment surgeries.
  • “We implement this mission through three programs: ECP GIVES, ECP EDUCATES and ECP CARES,” said Amy Jones, ECP Foundation President.

Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity

Retrieved on: 
Monday, May 1, 2023
Research, Pharmaceutical, Optical, Medical Devices, Clinical Trials, Science, Surgery, Biotechnology, Medical Supplies, Other Science, Health, Diabetes, Ophthalmology, ASCRS, Zimmer Biomet Robotics, Patient, OCT, Randomized controlled trial, News, NYSE, Glaucoma, Trifocal lenses, Capsulorhexis, Electronic, Intraocular pressure, EEG microstates, Cataract, Cataract surgery, Refractive surgery, SENTRY, American Society of Cataract and Refractive Surgery, Phacoemulsification, Intraocular lens, Micheletti, IOP, Surgeon, ABO, Vision system, Refraction, Trial of the century, Annual general meeting, IOL, Society, Veterinary medicine, Telescopic sight, Medical device, Dentistry, Alcon, MD

Alcon ASCRS event information and registration is available at MyAlconatASCRS.com .

Key Points: 
  • Alcon ASCRS event information and registration is available at MyAlconatASCRS.com .
  • “The pace of innovation happening across eye care is extraordinary, and as the industry leader, we are excited to be leading the charge at ASCRS 2023,” said Sergio Duplan, President, North America at Alcon.
  • evaluates a head-to-head comparison of distance and intermediate vision of Clareon monofocal IOL and TECNIS Eyhance* monofocal IOL.
  • For information on Alcon events and news at ASCRS, please visit MyAlconatASCRS.com .

Anti-blue Ray Myopia Lenses Market to Reach $ 4.76 billion by 2030: Cognitive Market Research

Retrieved on: 
Monday, April 3, 2023
Migraine, Headache, Partnership, Probability, Macular degeneration, Trifocal lenses, Retail, Coronavirus, COVID-19, Lens, Bifocals, Person, Computer, USD, Hospital, SWOT, Strategic management, Risk, Agent, SWOT analysis, Distribution, Clifton Springs Hospital & Clinic, Growth, Near-sightedness, Dry, Driver, Revenue, Telescope, Marketing, Video game

As per Cognitive Market Research analysis, rising consumer awareness about the benefits of using anti-blue ray myopia lenses and increasing demand for premium eyewear products among consumers is expected to drive the growth of the market.

Key Points: 
  • As per Cognitive Market Research analysis, rising consumer awareness about the benefits of using anti-blue ray myopia lenses and increasing demand for premium eyewear products among consumers is expected to drive the growth of the market.
  • Major findings during the study of the Anti-blue Ray Myopia Lenses Market:
    Among segments, the market is further classified into single, trifocal, bifocal, and others.
  • This is a crucial factor that can impede the expansion of the global market during the forecast period
    What are the trends in the Anti-blue Ray Myopia Lenses Market?
  • Anti-blue Ray Myopia Lenses Market – Type Outlook (Revenue, USD Billion, 2018 – 2030)

Global Anti-blue Ray Myopia Lenses Market Expected to Garner $5,361.10 Million in the 2022-2030 Timeframe, Growing at 7.6% CAGR | Report [300-Pages] by Research Dive

Retrieved on: 
Thursday, January 12, 2023
Exclusive, Migraine, Trifocal lenses, Hospital, Research, Bifocals, Growth, Myopia, Center for Urban and Regional Analysis, Single, Macular degeneration, Light-emitting diode, Coronavirus, Computer, Retail, Video game, Television

NEW YORK, Jan. 12, 2023 /PRNewswire/ -- Research Dive has added a new report to its offering titled, "Anti-blue Ray Myopia Lenses Market by Type (Single, Bifocal, Trifocal, and Others), Distribution Channel (Retail Stores, Hospital & Clinics, and E-Commerce Platforms), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2022-2030".

Key Points: 
  • As per the report, the global anti-blue ray myopia lenses market is predicted to grow at a stable CAGR of 7.6% in the 2022-2030 timeframe, thereby garnering $5,361.10 million by 2030.
  • Drivers: The anti-blue ray myopia lenses market is expected to witness a massive growth in its market size due to decreasing possibility of migraines and macular degeneration.
  • The report has divided the anti-blue ray myopia lenses market into certain segments based on type, distribution channel, and region.
  • By regional analysis, the anti-blue ray myopia lenses market in the Asia-Pacific region is expected to be the most profitable and rise with a CAGR of 6.6%.

Global Anti-blue Ray Myopia Lenses Market Expected to Garner $5,361.10 Million in the 2022-2030 Timeframe, Growing at 7.6% CAGR | Report [300-Pages] by Research Dive

Retrieved on: 
Thursday, January 12, 2023
Exclusive, Migraine, Trifocal lenses, Hospital, Research, Bifocals, Growth, Myopia, Center for Urban and Regional Analysis, Single, Macular degeneration, Light-emitting diode, Coronavirus, Computer, Retail, Video game, Television

NEW YORK, Jan. 12, 2023 /PRNewswire/ -- Research Dive has added a new report to its offering titled, "Anti-blue Ray Myopia Lenses Market by Type (Single, Bifocal, Trifocal, and Others), Distribution Channel (Retail Stores, Hospital & Clinics, and E-Commerce Platforms), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2022-2030".

Key Points: 
  • As per the report, the global anti-blue ray myopia lenses market is predicted to grow at a stable CAGR of 7.6% in the 2022-2030 timeframe, thereby garnering $5,361.10 million by 2030.
  • Drivers: The anti-blue ray myopia lenses market is expected to witness a massive growth in its market size due to decreasing possibility of migraines and macular degeneration.
  • The report has divided the anti-blue ray myopia lenses market into certain segments based on type, distribution channel, and region.
  • By regional analysis, the anti-blue ray myopia lenses market in the Asia-Pacific region is expected to be the most profitable and rise with a CAGR of 6.6%.

Wolfe Eye Clinic to Implement End-to-End Ophthalmology Suite from ModMed®

Retrieved on: 
Wednesday, October 6, 2021
Data Management, Health, Technology, Practice Management, Software, General Health, Optical, Modernizing Medicine, ICL, Elective surgery, Instagram, Efficiency, Health information management, Cataract, Practice management, Podiatry, Workflow, Otorhinolaryngology, Pain management, Software, Patient, AMD, Physician, Health, MD, Gastroenterology, LinkedIn, Astigmatism, Twitter, Family, Ophthalmology, Hurney, EHR, Dermatology, RCM, Trifocal lenses, Glaucoma, Blog, Industry, Medical device, Medicine, Hospital, ModMed, Wolfe Eye Clinic, MODMED, WOLFE EYE CLINIC

Additionally, Wolfe Eye Clinic wanted an active and engaged vendor with comprehensive software that could meet their needs.

Key Points: 
  • Additionally, Wolfe Eye Clinic wanted an active and engaged vendor with comprehensive software that could meet their needs.
  • For more information about the ModMed Ophthalmology suite, please visit ModMed at www.modmed.com/Ophthalmology
    ModMed has been Modernizing Medicine since 2010.
  • In medical practice since 1919, Wolfe Eye Clinic is a specialty medical eye care and surgical treatment center with locations across Iowa.
  • The specialists at Wolfe Eye Clinic diagnose, manage and surgically treat acute and chronic eye diseases, including cataracts , cornea disease , glaucoma , oculofacial plastic conditions , pediatric eye disease and retina disease .

Alcon to Highlight AcrySof IQ PanOptix Trifocal IOL Launch and Groundbreaking IOL Data at American Academy of Ophthalmology Annual Meeting

Retrieved on: 
Wednesday, October 9, 2019
Technology, Medical devices, Surgery, Medical Supplies, Audio, Video, Health, Optical, Corrective lenses, Perception, Senses, Medical specialties, Vision, Eye, Ophthalmology, Intraocular lens, IOL, Trifocal lenses, Progressive lens, Toric

The newly launched AcrySof IQ PanOptix Trifocal Intraocular Lens (IOL), along with findings from the AAO IRIS (Intelligent Research in Sight) Registry, will be part of the scientific program.

Key Points: 
  • The newly launched AcrySof IQ PanOptix Trifocal Intraocular Lens (IOL), along with findings from the AAO IRIS (Intelligent Research in Sight) Registry, will be part of the scientific program.
  • PanOptix, which received FDA-approval in August, is the first and only advanced trifocal lens approved in the US.
  • Paper Presentation, Tuesday, October 15, 11:03 AM 11:10 AM: Incidence of Monofocal Toric IOL Repositioning: Analysis of the AAO IRIS Registry; B.A.
  • Due to the design of multifocal IOLs, there are some side effects that can be associated with the AcrySof IQ PanOptix Trifocal IOL models.

Mattax Neu Prater Eye Center Now Offering First Trifocal Lens for Cataract Patients

Retrieved on: 
Tuesday, September 24, 2019
Medical specialties, Medicine, Senses, Vision, Corrective lenses, Eye, Ophthalmology, Cataract, Eye surgery, Trifocal lenses

SPRINGFIELD, Mo., Sept. 24, 2019 /PRNewswire-PRWeb/ --Mattax Neu Prater Eye Center now offers its cataract patients the AcrySof IQ PanOptix Trifocal Lens, the first and only trifocal intraocular replacement lens (IOL) available in the United States.

Key Points: 
  • SPRINGFIELD, Mo., Sept. 24, 2019 /PRNewswire-PRWeb/ --Mattax Neu Prater Eye Center now offers its cataract patients the AcrySof IQ PanOptix Trifocal Lens, the first and only trifocal intraocular replacement lens (IOL) available in the United States.
  • "Cataract correction technology is constantly evolving, so our team is always monitoring these advancements," says eye surgeon Dr. Jacob Thomas of Mattax Neu Prater.
  • That is why we are so excited to introduce our cataract patients to the PanOptix trifocal lens.
  • Together, they provide surgical, medical, and primary vision care, including:
    To learn more or request an appointment at Mattax Neu Prater Eye Center, call (417) 886-3937 or visit MattaxNeuPrater.com .

Moretsky Cassidy Performs Successful PanOptix Trifocal Lens Implant

Retrieved on: 
Thursday, September 12, 2019
Medical specialties, Medicine, Senses, Vision, Ophthalmology, Corrective lenses, Eye, Intraocular lens, IOL, Eye surgery, Trifocal lenses, Cataract

PHOENIX, Sept. 12, 2019 /PRNewswire/ -- We are proud to announce that Dr. Sanford Moretsky and Dr. Craig Cassidy, of Valley Eye Specialists, were amongst the first select group of eye surgeons nationally to implant the Alcon AcrySof IQ PanOptix Trifocal Intraocular Lens, after FDA approval.

Key Points: 
  • PHOENIX, Sept. 12, 2019 /PRNewswire/ -- We are proud to announce that Dr. Sanford Moretsky and Dr. Craig Cassidy, of Valley Eye Specialists, were amongst the first select group of eye surgeons nationally to implant the Alcon AcrySof IQ PanOptix Trifocal Intraocular Lens, after FDA approval.
  • The best way to correct the cataract is to remove the cloudy lens and replace it with an intraocular lens implant.
  • With the Alcon PanOptix lens, our patients can expect exceptional vision quality and a dramatic reduction or elimination in the use of glasses after surgery," said Dr. Cassidy.
  • To learn more about the Alcon Panoptix Trifocal IOL, call Moretsky Cassidy Vision Correction at 1.800.791.1513 or visit our website at www.arizonacataract.com .

PhysIOL® to Launch FineVision Triumf®- the First and Only Trifocal EDOF IOL - Raising the Bar for Presbyopia-Correction

Retrieved on: 
Thursday, September 12, 2019
Corrective lenses, Senses, Perception, Ophthalmology, Vision, Eye, RTT, Intraocular lens, Cataract surgery, Trifocal lenses, Presbyopia, IOL

WALTHAM, Mass., Sept. 12, 2019 /PRNewswire/ -- BVI through its PhysIOL subsidiary, the pioneer of trifocal technology, announces today the European launch of FineVision Triumf EDOF trifocal presbyopia correcting intraocular lens for patients undergoing cataract surgery.

Key Points: 
  • WALTHAM, Mass., Sept. 12, 2019 /PRNewswire/ -- BVI through its PhysIOL subsidiary, the pioneer of trifocal technology, announces today the European launch of FineVision Triumf EDOF trifocal presbyopia correcting intraocular lens for patients undergoing cataract surgery.
  • PhysIOL continues to lead the market with IOL innovation with the launch of the FineVision Triumf.
  • The FineVision Triumf is free of LCA at far and intermediate focus points where glare and halos appear.
  • Since PhysIOL launched the first FineVision IOL in 2010 patients have had a trifocal focal solution providing near, intermediate and distance vision correction, and offering spectacle independence.